What's new

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 30, Status: Authorised

Feb 18, 2025 - 15:46
 0
Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 30, Status: Authorised
Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 30, Status: Authorised
Read More

Tags:

Previous Article

Nvidia discloses investment into robotaxi firm WeRide

Next Article

Human medicines European public assessment report (EPAR): GoResp Digihaler (prev...

Related Posts

Executive Steering Group on Shortages and Safety of Medicinal Products

Executive Steering Group on Shortages and Safety of Med...

Feb 11, 2025  0

EMA human resources strategy: Priorities 2023-2025

Feb 9, 2025  0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 November 2025, 10:00 (CET) to 19 November 2025, 12:00 (CET)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0